GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway.

MLA

Mazzieri, Alessio, et al. “GLP-1 RAs and SGLT2i: Two Antidiabetic Agents Associated with Immune and Inflammation Modulatory Properties through the Common AMPK Pathway.” Frontiers in Immunology, Dec. 2023, pp. 1–6. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1163288.

APA

Mazzieri, A., Basta, G., Calafiore, R., & Luca, G. (2023). GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway. Frontiers in Immunology, 1–6. https://doi.org/10.3389/fimmu.2023.1163288

Chicago

Mazzieri, Alessio, Giuseppe Basta, Riccardo Calafiore, and Giovanni Luca. 2023. “GLP-1 RAs and SGLT2i: Two Antidiabetic Agents Associated with Immune and Inflammation Modulatory Properties through the Common AMPK Pathway.” Frontiers in Immunology, December, 1–6. doi:10.3389/fimmu.2023.1163288.